Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Merck & Co's CEO has portrayed innovative pharma firms as the good guys of the drug industry ahead of an expected showdown over pricing in 2017 with Donald Trump. Kenneth Frazier was talking in a ...

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country. | The recent ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 ...

Inhibikase Therapeutics (IKT) appointed Mark Iwicki as the company’s CEO, replacing Milton Werner, founder of Inhibikase, effective February ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

2) Merck’s Pipeline of Drugs Is Worth More Than $50 Billion In its Q4 conference call, Merck CEO Rob Davis stated they have 20 potential new pipeline treatment growth drivers, almost all of ...

Merck & Co Inc (MRK) reports robust sales growth driven by KEYTRUDA and WINREVAIR, while navigating GARDASIL demand issues in ...

A pharma giant expresses interest in a Stamford biotech company after striking a deal worth up to $1.3 billion for a New Haven firm late last year.

Merck Foundation Fashion Awards 2023 Winners Announced to Acknowledge their Work to Empower Infertile Women and Support Girl ...